Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lianbio ADR (NQ: LIAN ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Mar 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lianbio ADR < Previous 1 2 3 4 Next > What's Going On With LianBio (LIAN) Stock? March 15, 2024 LianBio shares are trading higher by some 84% to $0.35 Friday afternoon on continued volatility. The company in late February announced its intent to delist its ADSs from the Nasdaq Global Market. Via Benzinga Why Is LianBio (LIAN) Stock Moving Today? March 15, 2024 LianBio stock is incredibly volatile on Friday as heavy trading rocks LIAN amid plans for a voluntary delisting of the shares. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 15, 2024 It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning! Via InvestorPlace LianBio Announces Voluntarily Delisting from Nasdaq February 28, 2024 From LianBio Via GlobeNewswire B of A Securities Downgrades LianBio: Here's What You Need To Know January 03, 2024 Via Benzinga Why LianBio Stock Is Skyrocketing Today October 24, 2023 Investors are loving LianBio's new deal with Bristol Myers Squibb. Via The Motley Fool Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders February 17, 2024 LianBio, a Princeton-Shanghai biotech, has decided to call it quits. LianBio plans to stop all of its operations by the end of 2024, and it will distribute a $4.80 dividend/share ($528 million) to its... Via Talk Markets Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 13, 2024 Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance. Via Benzinga Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday February 13, 2024 U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities LianBio Announces Completion of Strategic Review February 13, 2024 LianBio to commence the wind down of its operations, including sale of remaining assets and reduction in force, delisting from Nasdaq and issuance of special cash dividend From LianBio Via GlobeNewswire Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal December 31, 2023 Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma to develop a novel bispecific macrophage engager, ES019, along with an unspecified program.... Via Talk Markets LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets December 26, 2023 From LianBio Via GlobeNewswire LianBio Announces Departure of Chief Financial Officer December 20, 2023 From LianBio Via GlobeNewswire LianBio Announces Departure of Chief Executive Officer December 19, 2023 From LianBio Via GlobeNewswire LianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra Biosciences December 06, 2023 From LianBio Via GlobeNewswire Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments December 02, 2023 LianBio received a $465 million buyout offer from Tang Capital Management. In addition, Tang also offered shareholders a contingent value right for 80% of net proceeds from any license or divestment of... Via Talk Markets LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences December 01, 2023 From LianBio Via GlobeNewswire LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 13, 2023 From LianBio Via GlobeNewswire LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis October 30, 2023 From LianBio Via GlobeNewswire ArcelorMittal, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session October 30, 2023 U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal October 28, 2023 Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its... Via Talk Markets Why LianBio Stock Is Shooting Through the Roof This Week October 27, 2023 LianBio stock is seeing explosive gains, and it's one of this week's biggest winners. Via The Motley Fool LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023 October 25, 2023 From LianBio Via GlobeNewswire Raymond James Maintains Outperform Rating for LianBio: Here's What You Need To Know October 25, 2023 Via Benzinga Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations October 24, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday. The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&P... Via Benzinga Topics Stocks Exposures US Equities Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 24, 2023 Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data. Via Benzinga Why Is LianBio (LIAN) Stock Up 130% Today? October 24, 2023 With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session October 24, 2023 Via Benzinga Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings October 24, 2023 U.S. stocks traded slightly higher midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.17% to 32,992.95 while the NASDAQ rose 0.06% to 13,023.65.... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why LianBio Stock Is Ripping Higher Today October 24, 2023 LianBio (NASDAQ: LIAN) shares are trading higher Tuesday after the company announced an agreement with Bristol Myers Squibb (NYSE: BMY) to purchase LianBio's exclusive rights to develop and... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.